Literature DB >> 28539779

Update on neuromyelitis optica: natural history and management.

Panitha Jindahra1,2, T Plant1,2.   

Abstract

Neuromyelitis optica or Devic disease is an inflammatory disorder of the central nervous system. It is caused by antibodies that attack aquaporin 4 water channels in the cell membrane of astrocytic foot processes at the blood brain barrier. It can involve the optic nerve, the spinal cord and beyond. Here we review its pathophysiology, clinical features, and therapy.

Entities:  

Keywords:  Devic disease; NMO spectrum disorders; NMO-IgG; Neuromyelitis optica; optic neuritis; transverse myelitis

Year:  2012        PMID： 28539779      PMCID： PMC5436187          DOI： 10.2147/EB.S8392

Source DB:  PubMed          Journal:  Eye Brain        ISSN： 1179-2744


  110 in total

1.  Posterior reversible encephalopathy syndrome after rituximab infusion in neuromyelitis optica.

Authors:  Alejandro Sánchez-Carteyron; Raquel Alarcia; José Ramón Ara; Jesús Martín
Journal:  Neurology       Date:  2010-05-04       Impact factor: 9.910

2.  Revised diagnostic criteria for neuromyelitis optica (NMO). Application in a series of suspected patients.

Authors:  Albert Saiz; Luigi Zuliani; Yolanda Blanco; Bruno Tavolato; Bruno Giometto; Francesc Graus
Journal:  J Neurol       Date:  2007-04-02       Impact factor: 4.849

3.  Neuromyelitis optica IgG predicts relapse after longitudinally extensive transverse myelitis.

Authors:  Brian G Weinshenker; Dean M Wingerchuk; Sandra Vukusic; Linda Linbo; Sean J Pittock; Claudia F Lucchinetti; Vanda A Lennon
Journal:  Ann Neurol       Date:  2006-03       Impact factor: 10.422

4.  Neuromyelitis optica.

Authors:  William M Carroll; Kazuo Fujihara
Journal:  Curr Treat Options Neurol       Date:  2010-05       Impact factor: 3.598

5.  Therapeutic efficacy of plasma exchange in NMO-IgG-positive patients with neuromyelitis optica.

Authors:  S Watanabe; I Nakashima; T Misu; I Miyazawa; Y Shiga; K Fujihara; Y Itoyama
Journal:  Mult Scler       Date:  2007-01       Impact factor: 6.312

6.  Wall-eyed bilateral internuclear ophthalmoplegia (WEBINO) syndrome in a patient with neuromyelitis optica spectrum disorder and anti-aquaporin-4 antibody.

Authors:  Koji Shinoda; Takuya Matsushita; Konosuke Furuta; Noriko Isobe; Tomomi Yonekawa; Yasumasa Ohyagi; Jun-ichi Kira
Journal:  Mult Scler       Date:  2011-02-07       Impact factor: 6.312

7.  Clinical characteristics, therapeutic outcomes of isolated atypical optic neuritis in China.

Authors:  Chuntao Lai; Guohong Tian; Wu Liu; Wenbing Wei; Toshiyuki Takahashi; Xiaojun Zhang
Journal:  J Neurol Sci       Date:  2011-04-05       Impact factor: 3.181

8.  Devic's neuromyelitis optica: a clinicopathological study of 8 patients.

Authors:  R N Mandler; L E Davis; D R Jeffery; M Kornfeld
Journal:  Ann Neurol       Date:  1993-08       Impact factor: 10.422

9.  Variable responses to rituximab treatment in neuromyelitis optica (Devic's disease).

Authors:  M Capobianco; S Malucchi; A di Sapio; F Gilli; A Sala; R Bottero; F Marnetto; C Doriguzzi Bozzo; A Bertolotto
Journal:  Neurol Sci       Date:  2007-08-10       Impact factor: 3.307

10.  Aquaporin-4 autoimmune syndrome and anti-aquaporin-4 antibody-negative opticospinal multiple sclerosis in Japanese.

Authors:  T Matsushita; N Isobe; T Matsuoka; N Shi; Y Kawano; X M Wu; T Yoshiura; Y Nakao; T Ishizu; J I Kira
Journal:  Mult Scler       Date:  2009-05-22       Impact factor: 6.312
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.